From the quarterly report below. Note the second paragraph. There might be significant interest or demand received for certain variation(s) of Edencrete that the company will want to pursue at this stage. Eg. Let's sell this at this concentration given we currently have limited volume. Yes, there is one brand here. So why don't we produce 86's as there are buyers in the queu and produce our RX350's later when orders or demand start flowing?Do you think it's wild speculation? Cheers
--------------------------
EdenCreteTM Marketing and New Product Development
Eden commenced a marketing study to assist Eden in the preparation of a comprehensive EdenCreteTM marketing plan. However after careful consideration it was decided to curtail this study for the time being.
Ongoing product development of EdenCreteTM is currently being undertaken to develop specialty variations of EdenCreteTM for specific specialist concrete applications.
Work on the first specialty application, for use in pre-cast concrete applications, has commenced and has achieving encouraging preliminary results. The first third-party trials of this new specialty version of EdenCreteTM are anticipated to occur during the September quarter.
- Forums
- ASX - By Stock
- EDE
- Monday's price guesses.
Monday's price guesses., page-51
-
- There are more pages in this discussion • 108 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EDE (ASX) to my watchlist
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.427M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
66 | 204793284 | 0.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 10206803 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
66 | 204793284 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.002 | 10206803 | 10 |
0.003 | 51095595 | 28 |
0.004 | 8849367 | 7 |
0.005 | 360000 | 1 |
0.006 | 2831956 | 1 |
Last trade - 16.12pm 15/07/2024 (20 minute delay) ? |
Featured News
EDE (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online